Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Gager, GM; von, Lewinski, D; Sourij, H; Jilma, B; Eyileten, C; Filipiak, K; Hülsmann, M; Kubica, J; Postula, M; Siller-Matula, JM.
Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart Failure.
Biomed Pharmacother. 2021; 143:112169 Doi: 10.1016/j.biopha.2021.112169 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG


Co-Autor*innen der Med Uni Graz
Sourij Harald
von Lewinski Dirk

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Sodium-glucose cotransporter 2 (SGLT2) inhibitors present a class of antidiabetic drugs, which inhibit renal glucose reabsorption resulting in the elevation of urinary glucose levels. Within the past years, SGLT2 inhibitors have become increasingly relevant due to their effects beyond glycemic control in patients with type 2 diabetes (T2DM). Although dedicated large trials demonstrated cardioprotective effects of SGLT2 inhibitors, the exact mechanisms responsible for those benefits have not been fully identified. Alterations in Ca2+ signaling and oxidative stress accompanied by excessive reactive oxygen species (ROS) production, fibrosis and inflammatory processes form cornerstones of potential molecular targets for SGLT2 inhibitors. This review focused on three hypotheses for SGLT2 inhibitor-mediated cardioprotection: ion homeostasis, oxidative stress and endothelial dysfunction.

Find related publications in this database (Keywords)
Heart failure
SGLT2 inhibitors
Ion homeostasis
Oxidative stress
Endothelial dysfunction
© Med Uni Graz Impressum